Quarterly report · Q2
7133.TEDINET S100S8NI
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 50
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.9bn | 2023-04-01 → 2023-09-30 | Standalone | Net sales |
| Revenue | ¥6.7bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.2bn | 2022-04-01 → 2022-09-30 | Standalone | Net sales |
| Operating income | ¥201m | 2023-04-01 → 2023-09-30 | Standalone | Operating income |
| Operating income | ¥255m | 2022-04-01 → 2022-09-30 | Standalone | Operating income |
| Ordinary income | ¥200m | 2023-04-01 → 2023-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥558m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥263m | 2022-04-01 → 2022-09-30 | Standalone | Ordinary income |
| Profit before tax | ¥200m | 2023-04-01 → 2023-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥263m | 2022-04-01 → 2022-09-30 | Standalone | Income before income taxes |
| Net income | ¥135m | 2023-04-01 → 2023-09-30 | Standalone | Profit loss |
| Net income | ¥383m | 2022-04-01 → 2023-03-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥179m | 2022-04-01 → 2022-09-30 | Standalone | Profit loss |
| Total assets | ¥4.0bn | at 2023-09-30 | Standalone | Assets |
| Total assets | ¥2.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥2.8bn | at 2022-09-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.4bn | at 2023-09-30 | Standalone | Liabilities |
| Total liabilities | ¥1.4bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.6bn | at 2023-09-30 | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-09-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥854m | at 2023-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥568m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥854m | at 2023-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥568m | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥680m | at 2022-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥720m | at 2022-03-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | ¥230m | 2023-04-01 → 2023-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥342m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥97m | 2022-04-01 → 2022-09-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥436m | 2023-04-01 → 2023-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥383m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥193m | 2022-04-01 → 2022-09-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥492m | 2023-04-01 → 2023-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥111m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥57m | 2022-04-01 → 2022-09-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥18.82 | 2023-04-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.72 | 2023-07-01 → 2023-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.92 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.33 | 2022-04-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.25 | 2022-07-01 → 2022-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥17.92 | 2023-04-01 → 2023-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥50.82 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥23.74 | 2022-04-01 → 2022-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| Equity ratio | 39.7% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.9% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.4% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 7,156,600 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,572,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,568,400 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥16m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥16m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | −¥6m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥230m |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.2bn |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.2bn |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥298m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥377m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥377m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥206m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥288m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥288m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥67m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥3.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥3.9bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥436m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥3.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥3.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥431m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥28m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥28m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥4m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥192m |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥339m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥275m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥275m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥144m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥65m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥65m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥40m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥3.1bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥3.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥443m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥3.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥3.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥447m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 442
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and deposits | CurrentQuarterInstant_NonConsolidatedMember | 853699000 | JPY |
| Accounts receivable trade | Prior1YearInstant_NonConsolidatedMember | 1152362000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant_NonConsolidatedMember | 1409884000 | JPY |
| Merchandise | Prior1YearInstant_NonConsolidatedMember | 185434000 | JPY |
| Merchandise | CurrentQuarterInstant_NonConsolidatedMember | 247010000 | JPY |
| Other ca | Prior1YearInstant_NonConsolidatedMember | 53853000 | JPY |
| Other ca | CurrentQuarterInstant_NonConsolidatedMember | 41410000 | JPY |
| Current assets | Prior1YearInstant_NonConsolidatedMember | 1959338000 | JPY |
| Current assets | CurrentQuarterInstant_NonConsolidatedMember | 2552004000 | JPY |
| Property plant and equipment | Prior1YearInstant_NonConsolidatedMember | 276584000 | JPY |
| Property plant and equipment | CurrentQuarterInstant_NonConsolidatedMember | 471973000 | JPY |
| Intangible assets | Prior1YearInstant_NonConsolidatedMember | 440496000 | JPY |
| Intangible assets | CurrentQuarterInstant_NonConsolidatedMember | 436600000 | JPY |
| Investments and other assets | Prior1YearInstant_NonConsolidatedMember | 238492000 | JPY |
| Investments and other assets | CurrentQuarterInstant_NonConsolidatedMember | 511041000 | JPY |
| Noncurrent assets | Prior1YearInstant_NonConsolidatedMember | 955573000 | JPY |
| Noncurrent assets | CurrentQuarterInstant_NonConsolidatedMember | 1419615000 | JPY |
| Assets | Prior1YearInstant_NonConsolidatedMember | 2914911000 | JPY |
| Assets | CurrentQuarterInstant_NonConsolidatedMember | 3971619000 | JPY |
| Accounts payable trade | Prior1YearInstant_NonConsolidatedMember | 669328000 | JPY |
| Accounts payable trade | CurrentQuarterInstant_NonConsolidatedMember | 886019000 | JPY |
| Short term loans payable | Prior1YearInstant_NonConsolidatedMember | - | JPY |
| Short term loans payable | CurrentQuarterInstant_NonConsolidatedMember | 300000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant_NonConsolidatedMember | 105582000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant_NonConsolidatedMember | 146708000 | JPY |
| Income taxes payable | Prior1YearInstant_NonConsolidatedMember | 84303000 | JPY |
| Income taxes payable | CurrentQuarterInstant_NonConsolidatedMember | 80068000 | JPY |
| Provision for bonuses | Prior1YearInstant_NonConsolidatedMember | 82072000 | JPY |
| Provision for bonuses | CurrentQuarterInstant_NonConsolidatedMember | 61221000 | JPY |
| Other cl | Prior1YearInstant_NonConsolidatedMember | 312973000 | JPY |
| Other cl | CurrentQuarterInstant_NonConsolidatedMember | 443797000 | JPY |
| Current liabilities | Prior1YearInstant_NonConsolidatedMember | 1254260000 | JPY |
| Current liabilities | CurrentQuarterInstant_NonConsolidatedMember | 1917816000 | JPY |
| Long term loans payable | Prior1YearInstant_NonConsolidatedMember | 88232000 | JPY |
| Long term loans payable | CurrentQuarterInstant_NonConsolidatedMember | 288238000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant_NonConsolidatedMember | 37473000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant_NonConsolidatedMember | 42636000 | JPY |
| Other ncl | Prior1YearInstant_NonConsolidatedMember | 51810000 | JPY |
| Other ncl | CurrentQuarterInstant_NonConsolidatedMember | 146092000 | JPY |
| Noncurrent liabilities | Prior1YearInstant_NonConsolidatedMember | 177515000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant_NonConsolidatedMember | 476967000 | JPY |
| Liabilities | Prior1YearInstant_NonConsolidatedMember | 1431776000 | JPY |
| Liabilities | CurrentQuarterInstant_NonConsolidatedMember | 2394783000 | JPY |
| Capital stock | Prior1YearInstant_NonConsolidatedMember | 185912000 | JPY |
| Capital stock | CurrentQuarterInstant_NonConsolidatedMember | 187121000 | JPY |
| Capital surplus | Prior1YearInstant_NonConsolidatedMember | 335922000 | JPY |
| Capital surplus | CurrentQuarterInstant_NonConsolidatedMember | 337131000 | JPY |
| Retained earnings | Prior1YearInstant_NonConsolidatedMember | 961300000 | JPY |
| Retained earnings | CurrentQuarterInstant_NonConsolidatedMember | 1095947000 | JPY |
| Treasury stock | Prior1YearInstant_NonConsolidatedMember | - | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |